Skip to main content
Quest Diagnostics

First Report of Severe Hemolysis Associated With SCARB1

American Society for Human Genetics Annual Meeting
ASHG 2022

Los Angeles, CA, October 25 - 29, 2022

Poster presentation: First Report of Severe Hemolysis Associated With SCARB1

Authors: Tanpaiboon P, Gotesma M, Panosyan E, Qing X, Dargan SK, Kuniyoshi KM, Perugu S, Rehan VK,  Smith LM, Graham JM Jr, Lin HJ

Specialties: Cardiovascular, Endocrinology, Genetics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.